Intranasal Administration of Mesenchymal Stem Cell-Derived Exosome Alleviates Hypoxic-Ischemic Brain Injury

Hypoxic-ischemic brain injury arises from inadequate oxygen delivery to the brain, commonly occurring following cardiac arrest, which lacks effective treatments. Recent studies have demonstrated the therapeutic potential of exosomes released from mesenchymal stem cells. Given the challenge of system...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Takuma Ikeda, Masahito Kawabori, Yuyuan Zheng, Sho Yamaguchi, Shuho Gotoh, Yo Nakahara, Erika Yoshie, Miki Fujimura
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	exosome mesenchymal stem cell intranasal administration hypoxic-ischemic brain injury inflammation
Online Access:	https://www.mdpi.com/1999-4923/16/4/446